Related Experiment Video
Updated: Jul 8, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Association Between Common Empiric Antibiotic Regimens and Clostridioides Difficile Infection in Pediatric
Andrew Hu1, Yao Tian1, Lynn Huang1
1Division of Pediatric Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Insights
Clostridioides difficile infection (CDI) is rare after pediatric appendicitis surgery. Piperacillin & Tazobactam (PT) showed lower CDI rates compared to Ceftriaxone & Metronidazole (CM), highlighting antibiotic stewardship needs.
Area of Science:
- Pediatric surgery
- Infectious diseases
- Antibiotic stewardship
Background:
- Clostridioides difficile infection (CDI) is a significant complication in children treated for appendicitis.
- Understanding CDI risk across different empiric antibiotic regimens is crucial for effective antibiotic stewardship.
Purpose of the Study:
- To compare the likelihood of CDI following appendectomy for acute appendicitis among three common empiric antibiotic regimens.
- To assess the impact of antibiotic choice and exposure on CDI rates in pediatric appendicitis patients.
Main Methods:
- Retrospective cohort study of 105,911 pediatric patients (ages 1-18) undergoing appendectomy.
- Comparison of Ceftriaxone & Metronidazole (CM), Piperacillin & Tazobactam (PT), and Cefoxitin regimens.
- Analysis of CDI within 28 days and percutaneous drainage within 30 days post-appendectomy.
Main Results:
- CDI occurred in 0.21% of patients, with higher rates for CM (0.29%) versus PT (0.15%) and Cefoxitin (0.18%).
- Piperacillin & Tazobactam (PT) was associated with a significantly lower likelihood of CDI compared to CM (OR, 0.48).
- Increased antibiotic regimen diversity and duration correlated with higher CDI risk; no difference in drainage procedures was observed.
Conclusions:
- CDI is infrequent after pediatric appendectomy.
- Piperacillin & Tazobactam (PT) demonstrated a lower CDI incidence than Ceftriaxone & Metronidazole (CM).
- Antibiotic stewardship should focus on minimizing mixed regimens and reducing overall antibiotic exposure to prevent CDI.
Background:
Clostridioides Difficile Infection (CDI) is a serious antibiotic related complication that has been reported among children undergoing treatment of appendicitis. CDI likelihood amongst different empiric antibiotic regimens for appendicitis remains unclear but likely has important implications for antibiotic stewardship.
Methods:
A retrospective cohort study of the Pediatric Health Information System was used to examine patients ages 1 through 18 who received operative management of acute appendicitis. Common empiric antibiotic regimens 1) Ceftriaxone & Metronidazole (CM) 2) Piperacillin & Tazobactam (PT) and 3) Cefoxitin were compared. Study outcomes were CDI within 28 days post-appendectomy and 30-day post-appendectomy percutaneous drainage procedures. Subset analyses were repeated to only include hospitals that standardized empiric antibiotic choice.
Results:
Of 105,911 patients, 220 (0.21 %) developed CDI. CDI was more common in patients that received CM (CM 0.29 % vs PT 0.15 % vs Cefoxitin 0.18 %; P < 0.01). On adjusted analysis, PT was associated with a lower likelihood of CDI (OR, 0.48; 95%CI, 0.31-0.74) compared to CM which was consistent in hospitals with standardized antibiotic choice. Exposure to more unique antibiotic regimens (OR, 1.70; 95 % CI, 1.50-1.93) and higher total antibiotic days (OR, 1.17; 95 % CI 1.13-1.21) were associated with an increased likelihood of CDI. There was no significant difference in the likelihood of post-appendectomy percutaneous drainage between antibiotic regimens.
Conclusions:
CDI is rare following appendectomy for pediatric appendicitis. While PT was associated with statistically lower rates of CDI compared to CM, antibiotic stewardship efforts to avoid mixed regimens and decrease overall antibiotic exposure warrant exploration.
Level Of Evidence:
Level III.
Related Concept Videos
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Combined Effects of Drugs: Synergism
Such synergistic combinations...

